Tesla, Rachel
Guhl, Charlotte https://orcid.org/0000-0002-5301-0064
Werthmann, Gordon C.
Dixon, Danielle
Cenik, Basar
Addepalli, Yesu
Liang, Jue https://orcid.org/0000-0002-9068-3292
Fass, Daniel M.
Rosenthal, Zachary
Haggarty, Stephen J. https://orcid.org/0000-0002-7872-168X
Williams, Noelle S.
Posner, Bruce A.
Ready, Joseph M. https://orcid.org/0000-0003-1305-9581
Herz, Joachim https://orcid.org/0000-0002-8506-3400
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS093382,, NS108115,)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG053391)
BrightFocus Foundation (A20135245, A2016396S)
Alzheimer's Association
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
Article History
Received: 29 May 2023
Accepted: 1 July 2024
First Online: 20 July 2024
Competing interests
: J.H. is a co-founder of Reelin Therapeutics Inc. and coinventor of a patent related to anti-Reelin strategies (Application Number: 15/763,047 and Publication Number: 20180273637). The remaining authors declare no competing interest.